Stevanato Group SpA
(NYSE : STVN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.67%601.961.0%$760.61m
DHRDanaher Corp. 1.45%312.960.7%$677.43m
ABTAbbott Laboratories 3.14%123.080.8%$638.64m
MDTMedtronic Plc 0.12%122.340.6%$534.62m
ISRGIntuitive Surgical, Inc. -0.12%335.900.8%$381.60m
ALGNAlign Technology, Inc. 0.71%598.506.3%$327.56m
BDXBecton, Dickinson & Co. 0.94%245.001.0%$313.44m
DXCMDexCom, Inc. 1.26%557.007.8%$288.90m
SYKStryker Corp. 0.64%272.601.3%$272.05m
EWEdwards Lifesciences Corp. 0.19%115.220.4%$260.10m
BSXBoston Scientific Corp. 0.52%44.361.0%$257.01m
IDXXIDEXX Laboratories, Inc. 1.29%649.283.8%$247.16m
AAgilent Technologies, Inc. 0.87%156.971.6%$218.21m
BAXBaxter International, Inc. 1.27%80.691.8%$192.25m
INMDInMode Ltd. -0.78%84.110.0%$177.07m

Company Profile

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates in Biopharmaceutical and Diagnostic Solutions and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.